HUT72302A
Catecholamine surrogates useful as beta-3 antagonists
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
33 members in 21 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 17128593 | United States of America | A | |
| 17128593 | United States of America | A | |
| 93171285 | – | – | – |
| US19930171285 | – | – | – |
Members33
| Document | Office | Kind | |
|---|---|---|---|
| FI946003A0 | Finland | A0 | |
| NO944969D0 | Norway | D0 | |
| HU9403694D0 | Hungary | D0 | |
| IL112060A0 | Israel | A0 | |
| IL112060D0 | Israel | D0 | |
| CA2138675A1 | Canada | A1 | |
| FI946003A | Finland | A | |
| NO944969L | Norway | L | |
| PL306452A1 | Poland | A1 | |
| EP0659737A2 | European Patent Office (EPO) | A2 | |
| AU8163594A | Australia | A | |
| KR950017940A | Republic of Korea | A | |
| JPH07206806A | Japan | A | |
| CN1109050A | China | A | |
| HUT72302AThis record | Hungary | A | |
| ZA9410213B | South Africa | B | |
| CZ326094A3 | Czechia | A3 | |
| RU94044343A | Russian Federation | A | |
| EP0659737A3 | European Patent Office (EPO) | A3 | |
| NZ270237A | New Zealand | A | |
| AU688417B2 | Australia | B2 | |
| NO303337B1 | Norway | B1 | |
| US5776983A | United States of America | A | |
| SG50477A1 | Singapore | A1 | |
| TW424082B | Taiwan Province of China | B | |
| HU220063B | Hungary | B | |
| EP0659737B1 | European Patent Office (EPO) | B1 | |
| AT235463T | Austria | T | |
| ATE235463T1 | Austria | T1 | |
| DE69432341D1 | Germany | D1 | |
| ES2194857T3 | Spain | T3 | |
| DE69432341T2 | Germany | T2 | |
| CA2138675C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Cancellation of final prot. due to non-payment of feeHMM4 | HMM4 |
Numbers
- Publication, DOCDB
- T72302
- Publication, EPODOC
- HUT72302
- Application
- 9403694
- Application, DOCDB
- 9403694
- Application, EPODOC
- HU19940003694
Titles
- English
- CATECHOLAMINE SURROGATES USEFUL AS BETA-3 ANTAGONISTS
Classification
- CPC, 14
- C07C311/08
- C07D213/64
- C07C311/13
- C07C311/21
- C07D213/38
- C07D213/69
- C07D317/58
- C07D317/66
- C07D333/20
- C07D333/58
- A61P1/00
- A61P3/10
- A61P3/04
- A61P3/08
- IPC, 30
- C07D295 12
- A61K31 18
- A61K31 215
- A61K31 275
- A61K31 336
- A61K31 357
- A61K31 36
- A61K31 38
- A61K31 381
- A61K31 44
- A61K31 4402
- A61K31 4406
- A61K31 4409
- A61P1 00
- A61P3 04
- A61P3 08
- A61P3 10
- C07C311 08
- C07C311 13
- C07C311 21
- C07D213 38
- C07D213 64
- C07D213 69
- C07D213 71
- C07D257 00
- C07D303 36
- C07D317 58
- C07D317 66
- C07D333 20
- C07D333 58